In vitro and in vivo antitumor effects of recombinant bispecific antibodies based on humanized anti-EGFR antibody.
Watanabe Y, Asano R, Arai K, Shimomura I, Ogata H, Kawaguchi H, Hayashi H, Ohtsuka H, Yoshida H, Katayose Y, Egawa S, Nakanishi T, Umetsu M, Yasui H, Ishida T, Imai K, Kudo T, Unno M, Kumagai I.
Watanabe Y, et al. Among authors: imai k.
Oncol Rep. 2011 Oct;26(4):949-55. doi: 10.3892/or.2011.1382. Epub 2011 Jul 4.
Oncol Rep. 2011.
PMID: 21743971